Comments

Roivant Sciences Stock Price, Quotes and Forecasts

Q: What sector and industry does Roivant Sciences (ROIV) operate in?

Roivant Sciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

ROIVNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$10.38

0.000.00%

Pre-Market: 4:00 PM EDT

Roivant Sciences (ROIV) Forecast

News Earnings Roivant Sciences (ROIV) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Roivant Sciences Stock Price, Quotes and Forecasts | NASDAQ:ROIV | Benzinga

Explore Roivant Sciences stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for ROIV.

Open	-
Close	-
Volume / Avg.	0 / 4.40M
Day Range	- - -
52 Wk Range	9.76 - 13.06
Market Cap	$7.41B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	32
Short Interest	7.97%
Days to Cover	9.51

Recent News

Tech Stocks Surge, Steelmakers Jump On Trump's 25% Tariffs, Copper Hits 9-Month Highs: What's Driving Markets Monday?

Wall Street bounced back on Monday, recovering from Friday's robust decline fueled by tariff concerns, as investors remained focused on strong earnings from the fourth-quarter reporting season while awaiting further clarity on trade policie

Piero Cingari

Trump Index: 6 Companies Linked to Trump's Cabinet Worth Watching

President Donald Trump's cabinet is often referred to as "The Avengers," with each member being accomplished in their field of expertise. Trump’s cabinet has an overwhelming number of successful businessmen and

MarketBeat

Trump Index: 6 Companies Linked to Trump's Cabinet Worth Watching

MarketBeat

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Sep 24

Nov 24

Feb

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.1

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	-
Close	-
Volume / Avg.	0 / 4.40M
Day Range	- - -
52 Wk Range	9.76 - 13.06
Market Cap	$7.41B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	32
Short Interest	7.97%
Days to Cover	9.51

About Roivant Sciences Ltd

Sector

Health Care

Industry

Biotechnology

Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the deli...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Roivant Sciences (ROIV) stock?

You can purchase shares of Roivant Sciences (NASDAQ:ROIV) through any online brokerage.

View our list of the best stock brokerages

Who are Roivant Sciences (ROIV) competitors?

Other companies in Roivant Sciences’s space includes: Legend Biotech (NASDAQ:LEGN), Sarepta Therapeutics (NASDAQ:SRPT), Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX) and Ionis Pharmaceuticals (NASDAQ:IONS).

What is the forecast, or price target, for Roivant Sciences (ROIV) stock?

Roivant Sciences has a consensus price target of $16.41.

What is the current price for Roivant Sciences (ROIV)?

The stock price for Roivant Sciences (NASDAQ: ROIV) is $10.38 last updated February 27, 2025 at 4:00 PM EST.

Does Roivant Sciences (ROIV) pay a dividend?

There are no upcoming dividends for Roivant Sciences.

When is Roivant Sciences (NASDAQ:ROIV) reporting earnings?

Roivant Sciences’s Q3 earnings are confirmed for Monday, February 10, 2025.

Is Roivant Sciences (ROIV) going to split?

There is no upcoming split for Roivant Sciences.

What sector and industry does Roivant Sciences (ROIV) operate in?

Roivant Sciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.